ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Rx.Health Partners with American Gastroenterological Association to Create the First-to-Market Gastroenterological Toolkit through RxStitchTM, Expanding its IBD and Perioperative Portfolio

The parties enter into a new innovation partnership to develop a digital toolkit with the goal of enhancing patient engagement and promoting digital transformation in the practice of gastroenterology

SECAUCUS, NJ, March 25, 2019 /24-7PressRelease/ -- On March 25th, the American Gastroenterological Association (AGA) and Rx.Health announced a new innovation partnership to develop a digital toolkit with the goal of enhancing patient engagement and promoting digital transformation in the practice of gastroenterology (GI). With an international membership of over 16,000 physicians and scientists, the AGA is widely recognized as the leading professional association fostering the science, practice, and advancement of GI. Dissemination of the joint offering will be powered by Rx.Health's digital prescription platform, RxUniverseTM.

The focus of the partnership will be the development and implementation of a GI-specific toolkit through utilization of the RxStitchTM engine, which takes seemingly disparate digital assets and combines them into a complementary suite of bundled services that enhance patient care outside of the clinical setting. RxStitchTM has already been utilized in successful implementations providing perioperative care and support bundles in specialties such as orthopedics and cardiology to improve patient activation and outcomes, while enhancing throughput and efficiency.

"Extending the application of RxStitchTM to GI was fundamental to our roadmap as we developed the program, and having the AGA as a partner provides the type of professional and clinical validation few associations can offer," said Andy Pfau, Rx.Health's Chief Operating Officer. "By combining the AGA's unparalleled subject matter expertise and eagerness to promote innovation within the field, we will be able to support health systems and ambulatory surgical centers with our full suite of perioperative, evidence-based digital solutions as a plug and play, turnkey solution."

Representatives from Rx.Health will be promoting the partnership at AGA's annual Digestive Disease Week®, which runs from May 18-21 in San Diego, CA. Sites interested in being considered in 2019 pioneer cohort can email engage@Rx.Health with their interest.

About the AGA

The American Gastroenterological Association is the trusted voice of the GI community. Founded in 1897, AGA has grown to more than 16,000 members from around the globe who are involved in all aspects of the science, practice and advancement of gastroenterology. The AGA Institute administers the practice, research and educational programs of the organization. www.gastro.org.

About Rx.Health

Rx.Health is changing the way both patients and providers think about digital medicine. A spinoff from the Mount Sinai Health System, Rx.Health's flagship product, RxUniverse, is the first enterprise-wide Digital Medicine delivery system that enables physicians to prescribe evidence-based mobile health applications, multi-media education, wearables, and therapeutics to patients at the point of care. GI Toolkit will cover major GI diseases and promote patient experience and recall during endoscopy while decreasing no-shows and poor bowel prep through evidence based text-messages and videos. Information on Rx.Health and RxUniverse is available at http://Rx.Health or follow Rx.Health on Twitter @Rx_Health.

---
Press release service and press release distribution provided by http://www.24-7pressrelease.com
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.